MRC · United KingdomPart of UKRI

Medical Research Council

The Medical Research Council is the UKRI council that funds medical and biomedical research, from basic science to clinical trials, and runs its own research units and institutes.

Funding and calls Official site

Open calls on pitute (20)

Calls from MRC that pitute holds open today. The funder's own page has every scheme.

Expression of interest: Chemical, biological, radiological and nuclear (CBRN) medical countermeasures R&DMedical Research Council (MRC) · United Kingdom · Closes 20 Oct 2026
Collaborate with the UK Human Functional Genomics InitiativeMedical Research Council (MRC) · United Kingdom · Closes 1 Nov 2026
UKRI translation: MRC proof of concept: stage twoMedical Research Council (MRC) · United Kingdom · Closes 4 Nov 2026
Purchase mid-range equipment for biomedical research: MRC EquipMedical Research Council (MRC) · United Kingdom · Closes 5 Nov 2026
UKRI Translation: MRC Impact Acceleration AwardsMedical Research Council (MRC) · United Kingdom · Closes 11 Nov 2026
Longitudinal population studies strategic prioritisation exerciseMedical Research Council (MRC) · United Kingdom · Closes 17 Nov 2026
UKRI Translation: MRC Proof of Concept: stage oneMedical Research Council (MRC) · United Kingdom · Closes 18 Nov 2026
UK Obesity Research Institute: full application

Recently funded

The newest running awards in UKRI Gateway to Research, the funder's public register.

Next Gen HSC GT for IEI: Developing the next generation of haematopoietic stem cell gene therapies for inborn errors of immunityHannah Al Yousuf · University College London · From 30 May 2027 · £459,532
Collaborative Union of Research Expertise (CURE): Investigating the oxytocin receptor mechanism in chronic visceral pain (CVP) suppressionDavid Bulmer · University of Cambridge · From 31 Dec 2026 · £256,890
Identifying Small-molecule Activators Of Kinesin Using An AstraZeneca High-throughput ScreenIsabel Palacios · Queen Mary University of London · From 31 Dec 2026 · £255,879
Understanding how stress and negative affect exacerbate chronic neuropathic pain: Unlocking new therapeutic avenues (STRESSPAIN)Kirsty Bannister · Imperial College London · From 29 Sept 2026 · £262,564
MRC CoRE in Restorative ImmunologyAdam Croft · University of Birmingham · From 29 Sept 2026 · £21,647,682
Mapping the Storm: Defining Disease Trajectories in Adult HLH Using Longitudinal Clinical and Proteomic BiomarkersAmelia Holloway · University College London · From 29 Sept 2026 · £418,450
Targeting vasculogenic mimicry to treat relapsed and metastatic rhabdomyosarcomaJoseph Wragg · University of Birmingham · From 29 Sept 2026 · £2,451,380
Decoding and Harnessing U2snRNP’s Antiviral Function for RNA Virus SuppressionAlfredo Castello · University of Glasgow · From 29 Sept 2026 · £842,381

Contains public sector information licensed under the Open Government Licence v3.0.

Recently funded

The newest running awards in UKRI Gateway to Research, the funder's public register.

Next Gen HSC GT for IEI: Developing the next generation of haematopoietic stem cell gene therapies for inborn errors of immunityHannah Al Yousuf · University College London · From 30 May 2027 · £459,532
Collaborative Union of Research Expertise (CURE): Investigating the oxytocin receptor mechanism in chronic visceral pain (CVP) suppressionDavid Bulmer · University of Cambridge · From 31 Dec 2026 · £256,890
Identifying Small-molecule Activators Of Kinesin Using An AstraZeneca High-throughput ScreenIsabel Palacios · Queen Mary University of London · From 31 Dec 2026 · £255,879
Understanding how stress and negative affect exacerbate chronic neuropathic pain: Unlocking new therapeutic avenues (STRESSPAIN)Kirsty Bannister · Imperial College London · From 29 Sept 2026 · £262,564
MRC CoRE in Restorative ImmunologyAdam Croft · University of Birmingham · From 29 Sept 2026 · £21,647,682
Mapping the Storm: Defining Disease Trajectories in Adult HLH Using Longitudinal Clinical and Proteomic BiomarkersAmelia Holloway · University College London · From 29 Sept 2026 · £418,450
Targeting vasculogenic mimicry to treat relapsed and metastatic rhabdomyosarcomaJoseph Wragg · University of Birmingham · From 29 Sept 2026 · £2,451,380
Decoding and Harnessing U2snRNP’s Antiviral Function for RNA Virus SuppressionAlfredo Castello · University of Glasgow · From 29 Sept 2026 · £842,381

Contains public sector information licensed under the Open Government Licence v3.0.

Open calls on pitute (20)

Recently funded

Related funders

Recently funded